Bioventus Inc. (BVS) Investor Relations Documents

Bioventus Inc. (BVS) investor relations documents from the company's IR site: 3 presentations, 31 press releases; latest deck 2026-03-05. Read in-app with summaries. First-party data.

Q4'25 Earnings Call Slides — Bioventus reported Q4 2025 net sales of $158 million and net income of $17 million, reflecting organic revenue growth of 10% and improved operational margins.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-05Press releaseBioventus Reports Second Quarter Financial Results
2026-07-29Press releaseBioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026
2026-06-02Press releaseBioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference
2026-04-28Press releaseBioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
2026-03-05PresentationQ4'25 Earnings Call Slides
2026-03-05Press releaseBioventus Announces Fourth Quarter and Full Year 2025 Financial Results
2026-02-24Press releaseBioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026
2026-01-06Press releaseBioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
2025-10-28Press releaseBioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
2025-07-29Press releaseBioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
2025-04-28Press releaseBioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
2025-03-11Press releaseBioventus Announces Fourth Quarter and Full Year 2024 Financial Results
2025-02-28Press releaseBioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025
2024-11-05Press releaseBioventus Reports Third Quarter Financial Results
2024-10-29Press releaseBioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
2024-08-06PresentationQ2'24 Earnings Call Slides
2024-08-06Press releaseBioventus Reports Second Quarter Financial Results
2024-07-30Press releaseBioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
2024-05-07PresentationQ1'24 Earnings Call Slides
2024-05-07Press releaseBioventus Reports First Quarter Financial Results
2024-03-12Press releaseBioventus Announces Fourth Quarter and Full Year 2023 Financial Results
2023-11-07Press releaseBioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
2023-08-04Press releaseBioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
2023-05-15Press releaseBioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 202
2023-03-31Press releaseBioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
2022-11-21Press releaseBioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance
2022-11-08Press releaseBioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance
2022-08-11Press releaseBioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance
2022-05-10Press releaseBioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance
2022-03-10Press releaseBioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance
2022-01-11Press releaseBioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue
2021-11-09Press releaseBioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance
Press releaseBioventus to Provide CVS Caremark with its Portfolio of Preferred Options for Knee Osteoarthritis Patients Seeking Pain
Press releaseBioventus Reports First Quarter Financial Results

BVS overview · BVS earnings · BVS financials · BVS KPIs · BVS ownership · BVS peers · BVS filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.